Mepilex Ag is a revolutionary dressing that utilizes the powerful antimicrobial action of silver. Mepilex Ag begins inactivating pathogens, including MRSA & VRE, within 30 minutes and has effective sustained release of silver for up to 7 days. It may be used on a wide range of exuding wounds such as leg and foot ulcers, pressure ulcers, partial thickness burns, and around pin sites for hardware.
Safetac, silver and exudate
management: A unique combination.
Targeting bacteria aggressively.
Mepilex Ag offers immediate, sustained and effective antimicrobial protection to lower bacteria and minimize discomfort to the patient. The key to Mepilex Ag’s effectiveness is silver, which acts as a protective barrier against wound complicating pathogens such as:
Bacillus cereus, Corynebacterium jeikeium,
Streptococcus pyogenes, Enterococcus faecalis,
Enterococcus faecium, Enterococcus faecalis (VRE),
Enterococcus faecium (VRE), Staphylococcus
aureus and MRSA ATTC 43300
Acinetobacter baumannii, Aeromonas hydrophilia,
Bordetella trematum, Moraxella canis, Enterobacter
cloacae, Klebsiella pneumoniae, Proteus vulgaris,
Salmonella enterica, Serratia marcescens,
Pseudomonas aeruginosa, Pseudomonas
Clostridium perfringens, Finegoldia magna,
Candida albicans, Candida guillermondi
* For General Recommendations for Routine Prevention and Control of MDROs in Healthcare Settings, please click here.
For more topics on infection prevention, please click here to visit the Institute for Healthcare Improvement.
* Siegel, Jane D., et al. Management of Multi-Resistant Organisms in Healthcare settings, 2006 (Electronic Version).
Retrived Jan 10, 2008
from http://www.cdc.gov/ncidod/dhqp/pdf/ar/MDROGuideline2006.pdf; http://www.visualdxhealth.com/diseaseGroups/mrsa.htm; and Navy Environmental Health Center, Guidelines for the Management of Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections in the US Navy and Marine Corps, August 2006.